Isras Investment (TASE:ISRS) 31% Below Fair Value After Strong First Half Results

Isras Investment (TASE:ISRS) has drawn investor attention after reporting second quarter and first half 2026 results, with sales, revenue and net income figures all higher than the same periods last year.

The latest 1-day share price return of 0.66% and 7-day gain of 1.34% leave Isras Investment trading at ₪807.4. However, the share price is still down 18.73% year to date, while the 5-year total shareholder return of 50.33% shows a much stronger longer term picture, suggesting recent momentum has softened even as interest around the earnings release picks up.

Scan how Isras Investment compares with other income-focused real estate stocks by reviewing the hand picked 416 dividend fortresses that could suit a similar earnings driven thesis.

Isras Investment now trades below an estimated intrinsic value, even after the recent share price uptick. Is that discount a sign that the market is too cautious, or a fair reflection of the risks around its earnings profile?

Price-to-Earnings of 9.5x: Is it justified?

On simple earnings terms, Isras Investment looks cheaper than many peers. The stock trades on a P/E of 9.5x, while the last close was ₪807.4 and the broader IL market average multiple is 14.9x.

The P/E ratio compares the current share price with the company’s earnings per share. For an income producing real estate business like Isras Investment, it gives a quick sense of how much investors are paying for each unit of reported profit.

With Isras Investment on 9.5x earnings compared with the IL Real Estate industry average of 12.7x, the market is assigning a lower earnings multiple than many domestic peers. That discount comes alongside a track record of earnings that have declined 9.3% per year over the past 5 years and a recent year in which earnings fell 5.2%. This may help explain why investors are not paying an industry level multiple despite the company’s long operating history and diversified Israeli portfolio.

See what the numbers say about this price — find out in our valuation breakdown..

Result: Price-to-Earnings of 9.5x

However, this lower P/E and implied intrinsic discount could also point to market concerns around Isras Investment’s concentrated Israel exposure and its earnings volatility.

Find out about the key risks to this Isras Investment narrative.

Another View on Isras Investment using our DCF model

The P/E discount suggests Isras Investment might be cheap, yet the SWS DCF model points in a different direction. At a share price of ₪807.4 and an estimated future cash flow value of ₪611.64, the stock screens as overvalued on this method. That raises a key question: Which signal should matter more for you right now?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Isras Investment for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 267 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals on value, risk and reward around Isras Investment, it may be helpful to review the underlying data yourself and move quickly to form a balanced view using the 1 key reward and 4 important warning signs.

Looking for more investment ideas beyond Isras Investment?

If you like the income and valuation angle around Isras Investment, do not stop here. Use the broader market to cross check ideas and uncover fresh opportunities.

• Target consistent income streams by reviewing the hand picked 416 dividend fortresses that spotlight companies with stronger yield potential.
• Hunt for potential value opportunities using the focused 267 high quality undervalued stocks that highlights stocks with solid fundamentals trading at a discount.
• Prioritise capital protection by scanning the curated 300 resilient stocks with low risk scores that concentrates on companies with more resilient risk profiles.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com